Chan Heng Fai Ambrose - 31 Mar 2025 SCHEDULE 13D Report for IMPACT BIOMEDICAL INC. Common Stock

Filing Manager
Chan Heng Fai Ambrose
Reporting Manager
Heng Fai Ambrose Chan
Security
IMPACT BIOMEDICAL INC. Common Stock
Shares outstanding
12,078,391 shares
Disclosed Ownership
2,041,248 shares
Ownership
16.9%
Form type
SCHEDULE 13D
Filing time
02 Apr 2025, 21:55:59 UTC
Date of event
31 Mar 2025
Next filing
04 Apr 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Heng Fai Ambrose Chan 16.9% 2,041,248 0 2,041,248 /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, an Individual 0001261725
Alset Inc. 16.9% 2,041,248 0 2,041,248 /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, Chief Executive Officer, Alset Inc. 0001750106
Alset International Limited 10.8% 1,307,190 0 1,307,190 /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, Chief Executive Officer, Alset International Limited 0001660984
Global Biomedical Pte. Ltd. 3.8% 453,286 0 453,286 /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, Director, Global Biomedical Pte. Ltd. 0001823066